SI1432417T1 - Substituirane benzimidazolne spojine in njihova uporaba za zdravljenje raka - Google Patents

Substituirane benzimidazolne spojine in njihova uporaba za zdravljenje raka

Info

Publication number
SI1432417T1
SI1432417T1 SI200230686T SI200230686T SI1432417T1 SI 1432417 T1 SI1432417 T1 SI 1432417T1 SI 200230686 T SI200230686 T SI 200230686T SI 200230686 T SI200230686 T SI 200230686T SI 1432417 T1 SI1432417 T1 SI 1432417T1
Authority
SI
Slovenia
Prior art keywords
cancer
treatment
benzimidazole compounds
substituted benzimidazole
substituted
Prior art date
Application number
SI200230686T
Other languages
English (en)
Inventor
Francois Clerc
Francois Hamy
Isabelle Depaty
Odile Angouillant-Boniface
Stephanie Deprets
Chantal Carrez
Manfred Roesner
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of SI1432417T1 publication Critical patent/SI1432417T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C07D235/32—Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
SI200230686T 2001-09-26 2002-09-26 Substituirane benzimidazolne spojine in njihova uporaba za zdravljenje raka SI1432417T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01402460A EP1298125A1 (en) 2001-09-26 2001-09-26 Substituted benzimidazole compounds and their use for the treatment of cancer
PCT/EP2002/011353 WO2003028721A2 (en) 2001-09-26 2002-09-26 Substituted benzimidazole compounds and their use for the treatment of cancer
EP02772370A EP1432417B1 (en) 2001-09-26 2002-09-26 Substituted benzimidazole compounds and their use for the treatment of cancer

Publications (1)

Publication Number Publication Date
SI1432417T1 true SI1432417T1 (sl) 2008-08-31

Family

ID=8182891

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200230686T SI1432417T1 (sl) 2001-09-26 2002-09-26 Substituirane benzimidazolne spojine in njihova uporaba za zdravljenje raka

Country Status (35)

Country Link
US (1) US7041668B2 (sl)
EP (2) EP1298125A1 (sl)
JP (1) JP4510450B2 (sl)
KR (1) KR100891439B1 (sl)
CN (1) CN100346786C (sl)
AR (1) AR037096A1 (sl)
AT (1) ATE386517T1 (sl)
AU (1) AU2002337151B2 (sl)
BR (1) BR0212856A (sl)
CA (1) CA2461622C (sl)
CO (1) CO5570675A2 (sl)
CY (1) CY1107953T1 (sl)
DE (1) DE60225159T2 (sl)
DK (1) DK1432417T3 (sl)
EA (1) EA006802B1 (sl)
ES (1) ES2301682T3 (sl)
GT (1) GT200200190A (sl)
HK (1) HK1068551A1 (sl)
HR (1) HRPK20040293B3 (sl)
HU (1) HUP0401756A3 (sl)
IL (1) IL161059A0 (sl)
ME (1) MEP16808A (sl)
MX (1) MXPA04002042A (sl)
MY (1) MY135339A (sl)
NO (1) NO327008B1 (sl)
NZ (1) NZ531246A (sl)
PA (1) PA8555501A1 (sl)
PE (1) PE20030427A1 (sl)
PL (1) PL369527A1 (sl)
PT (1) PT1432417E (sl)
RS (1) RS50896B (sl)
SI (1) SI1432417T1 (sl)
UY (1) UY27452A1 (sl)
WO (1) WO2003028721A2 (sl)
ZA (1) ZA200401887B (sl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011250847B2 (en) * 2003-06-23 2013-06-20 Bhi Limited Partnership Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
JP2007527412A (ja) * 2003-10-24 2007-09-27 エグゼリクシス， インコーポレイテッド Ｔａｏキナーゼモジュレーターおよび使用方法
DE102004010207A1 (de) 2004-03-02 2005-09-15 Aventis Pharma S.A. Neue 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate
FR2868421B1 (fr) * 2004-04-01 2008-08-01 Aventis Pharma Sa Nouveaux benzothiazoles et leur utilisation comme medicaments
EP1598348A1 (en) 2004-05-18 2005-11-23 Aventis Pharma Deutschland GmbH Novel pyridazinone derivatives as inhibitors of CDK2
US8044100B2 (en) 2004-12-22 2011-10-25 Bellus Health Inc. Methods and compositions for treating amyloid-related diseases
UA92180C2 (en) * 2005-09-06 2010-10-11 Смиткляйн Бичам Корпорейшн Benzimidazole thiophene compounds as plk inhibitors
FR2891273B1 (fr) * 2005-09-27 2007-11-23 Aventis Pharma Sa NOUVEAUX DERIVES BENZIMIDAZOLES ET BENZOTHIAZOLES, LEUR PREPARATION ET LEUR UTILISATION PHARMACEUTIQUE NOTAMMENT COMME INHIBITEURS DE CMet
KR101742179B1 (ko) 2006-10-12 2017-05-31 비에이치아이 리미티드 파트너쉽 3-아미노-1-프로판설폰산을 전달하기 위한 방법, 화합물, 조성물 및 비히클
PA8792501A1 (es) 2007-08-09 2009-04-23 Sanofi Aventis Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol,su procedimiento de preparación,su aplicación como medicamentos,composiciones farmacéuticas y nueva utilización principalmente como inhibidores de met.
UA113277C2 (xx) * 2007-10-12 2017-01-10 Комбінація кристалічної форми1 2-((r)-2-метилпіролідин-2-іл)-1н-бензімідазол-4-карбоксаміду та протиракового лікарського засобу
FR2922550B1 (fr) 2007-10-19 2009-11-27 Sanofi Aventis Nouveaux derives de 6-aryl/heteroalkyloxy benzothiazole et benzimidazole, application comme medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de cmet
FR2941950B1 (fr) 2009-02-06 2011-04-01 Sanofi Aventis Derives de 6-(6-o-substitue-triazolopyridazine-sulfanyl) benzothiazoles et benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
FR2941949B1 (fr) 2009-02-06 2011-04-01 Sanofi Aventis Derives de 6-(6-o-cycloalkyl ou 6-nh-cycloalkyl- triazolopyridazine-sulfanyl)benzothiazoles et benzimidazoles preparation, application comme medicaments et utilisation comme inhibiteurs de met.
FR2941952B1 (fr) 2009-02-06 2011-04-01 Sanofi Aventis Derives de 6-(6-substitue-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles et 5-fluoro-benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
FR2941951B1 (fr) 2009-02-06 2011-04-01 Sanofi Aventis Derives de 6-(6-nh-substitue-triazolopyridazine-sulfanyl) benzothiazoles et benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
WO2011091152A1 (en) * 2010-01-22 2011-07-28 Pablo Gastaminza Inhibitors of hepatitis c virus infection
IL310959A (en) 2015-08-25 2024-04-01 Alnylam Pharmaceuticals Inc Methods and preparations for treating a disorder related to the PCSK9 gene

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2441201C2 (de) * 1974-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Anthelminthisch wirksame 2-Carbalkoxyamino-5(6)-phenyl-sulfonyloxy-benzimidazole und Verfahren zu ihrer Herstellung
DE2541752A1 (de) * 1975-09-19 1977-03-24 Hoechst Ag Anthelminthisch wirksame 2-carbalkoxyamino-5(6)-phenyl-sulfonyloxy- benzimidazole und verfahren zu ihrer herstellung
DE3247615A1 (de) * 1982-12-23 1984-07-05 Hoechst Ag, 6230 Frankfurt Substituierte phenylsulfonyloxybenzimidazolcarbaminate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB9900752D0 (en) * 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
US6693125B2 (en) * 2001-01-24 2004-02-17 Combinatorx Incorporated Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders

Also Published As

Publication number Publication date
PE20030427A1 (es) 2003-06-20
ZA200401887B (en) 2005-05-31
EA006802B1 (ru) 2006-04-28
CO5570675A2 (es) 2005-10-31
GT200200190A (es) 2003-11-11
MXPA04002042A (es) 2004-06-07
DE60225159D1 (de) 2008-04-03
NO20041214L (no) 2004-06-24
YU21404A (sh) 2006-08-17
MY135339A (en) 2008-03-31
UY27452A1 (es) 2003-02-28
PA8555501A1 (es) 2003-06-30
NO327008B1 (no) 2009-04-06
DK1432417T3 (da) 2008-06-16
CN100346786C (zh) 2007-11-07
HRPK20040293B3 (en) 2007-06-30
CA2461622A1 (en) 2003-04-10
CA2461622C (en) 2008-12-02
ES2301682T3 (es) 2008-07-01
AU2002337151B2 (en) 2007-04-26
MEP16808A (en) 2010-06-10
EP1432417B1 (en) 2008-02-20
PL369527A1 (en) 2005-05-02
JP2005504112A (ja) 2005-02-10
HK1068551A1 (en) 2005-04-29
KR20040048904A (ko) 2004-06-10
HUP0401756A3 (en) 2005-06-28
EA200400475A1 (ru) 2004-08-26
CN1558761A (zh) 2004-12-29
KR100891439B1 (ko) 2009-04-03
HRP20040293A2 (en) 2005-06-30
WO2003028721A2 (en) 2003-04-10
US20050014811A1 (en) 2005-01-20
EP1432417A2 (en) 2004-06-30
DE60225159T2 (de) 2009-02-19
AR037096A1 (es) 2004-10-20
JP4510450B2 (ja) 2010-07-21
PT1432417E (pt) 2008-05-23
NZ531246A (en) 2006-06-30
ATE386517T1 (de) 2008-03-15
BR0212856A (pt) 2004-09-14
WO2003028721A3 (en) 2003-12-11
IL161059A0 (en) 2004-08-31
EP1298125A1 (en) 2003-04-02
HUP0401756A2 (hu) 2005-01-28
CY1107953T1 (el) 2013-09-04
US7041668B2 (en) 2006-05-09
RS50896B (sr) 2010-08-31

Similar Documents

Publication Publication Date Title
HK1068551A1 (en) Substituted benzimidazole compounds and their use for the treatment of cancer
HK1086488A1 (en) Compound and use thereof for the treatment of cancer
PL370029A1 (en) 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
AU6048201A (en) Quinazoline derivatives for the treatment of tumours
PL375532A1 (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
IL157425A0 (en) Treatment of solid tumours with paramycin derivatives
AU6147401A (en) Compositions and methods for the treatment of cancer
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
HK1072443A1 (en) Immunoconjugates for the treatment of tumours
HUP0400314A3 (en) Pharmaceutical combinations for the treatment of cancer
EP1446012A4 (en) Bacteriolytic combination therapy for the treatment of tumors
HUS2200036I1 (hu) Dihidroimidazolonok alkalmazása kutyák kezelésére
IL159887A0 (en) Combination therapy for the treatment of cancer
EP1442062A4 (en) METHOD FOR TREATING CARCINOMA
AU2003212634A8 (en) Compounds useful in the treatment of cancer
IL165839A0 (en) Compounds useful for the treatment of cancer compositions thereof and methods therewith
PL368035A1 (en) Compositions and methods for the treatment of cancer
PL375564A1 (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
LT1496918T (lt) Natrio meta-arsenito naudojimas navikams gydyti
AU2002366195A8 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
AU2002304883A1 (en) Device for the treatment of tumours
SI1680405T1 (sl) Bengamidni derivati in njihova uporaba za zdravljenje rakavih bolezni
AU2002350513A1 (en) Use of solasonine for the treatment of skin tumors
GB0129388D0 (en) Use of compounds for treating cancer